🇺🇸 FDA
Patent

US 12329756

Regulation of eIF4E activity for migraine therapy

granted A61KA61K31/05A61K31/167

Quick answer

US patent 12329756 (Regulation of eIF4E activity for migraine therapy) held by The Board of Regents of the University of Texas System expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/05, A61K31/167, A61K31/19, A61K31/343